Climb Bio (CLYM) Other Accumulated Expenses (2021 - 2026)
Climb Bio (CLYM) posted Other Accumulated Expenses of $113000.0 for Q1 2026, up 91.53% on a QoQ basis from $59000.0 in Q4 2025, and down 88.7% year-over-year from $1.0 million in Q1 2025.
Climb Bio (CLYM) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
Climb Bio's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $113000.0 for Q1 2026.
- Quarterly Other Accumulated Expenses fell 88.7% year-over-year to $113000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113000.0 (down 88.7% YoY) and the FY2025 annual result came in at $59000.0, down 33.71% from the prior year.
- Other Accumulated Expenses was $113000.0 for Q1 2026 at Climb Bio, up from $59000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.3 million in Q2 2024 and bottomed at $22000.0 in Q3 2024.
- A 4-year average of $312200.0 and a median of $101000.0 in 2024 frame the typical range for Other Accumulated Expenses.
- Peak annual rise in Other Accumulated Expenses reached 250.0% in 2025, while the deepest fall reached 97.12% in 2025.
- Climb Bio's Other Accumulated Expenses stood at $138000.0 in 2023, then plunged by 35.51% to $89000.0 in 2024, then tumbled by 33.71% to $59000.0 in 2025, then jumped by 91.53% to $113000.0 in 2026.
- Business Quant data shows CLYM's Other Accumulated Expenses at $113000.0 in Q1 2026, $59000.0 in Q4 2025, and $77000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 113,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 89,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 304,000.00 |
| Dec 31, 2023 | 138,000.00 |
| Jun 30, 2021 | 575,000.00 |